About the Event
What does it take to innovate in the pharmaceutical industry? Few people know more about that topic than Dr. David Pyott, former CEO of Allergan.
By driving innovation through investments in R&D, Dr. Pyott transformed Allergan from a small eye care company into a global specialty pharmaceutical and medical device company, overseeing $68 billion in market value growth.
Join our fireside chat with Dr. Pyott and Jeff Missling, CEO of SpineThera, a company whose innovative platform technology has the potential to disrupt the $134B market for the treatment of chronic back pain.